NCT03008915 Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency Status COMPLETED Phase PHASE2
NCT02990403 The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss Status UNKNOWN Phase PHASE4
NCT02986594 Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With Thrombophilla Status UNKNOWN Phase PHASE4
NCT02975076 Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Study Status UNKNOWN Phase NA
NCT02966002 Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients Status TERMINATED Phase PHASE4
NCT02965703 Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02960126 Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk Status UNKNOWN Phase PHASE3
NCT02929888 Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients Status UNKNOWN Phase PHASE2/PHASE3
NCT02927249 Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy Status TERMINATED Phase PHASE3
NCT02922673 The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human Endotoxemia Status COMPLETED Phase NA
NCT02895113 Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes Status UNKNOWN Phase PHASE3
NCT02878772 Vinpocetine Inhibits NF-κB-dependent Inflammation in Acute Ischemic Stroke Patients Status COMPLETED Phase PHASE2/PHASE3
NCT02869009 Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke Status COMPLETED Phase PHASE3
NCT02848339 Aspirin Desensitization Registry in Patients With Aspirin Hypersensitivity Status COMPLETED Phase N/A
NCT02837003 3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation Status UNKNOWN Phase N/A
NCT02832531 INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority Status WITHDRAWN Phase PHASE3